PuSH - Publikationsserver des Helmholtz Zentrums München

80 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Kowall, B.* et al.: Incidence rates of type 2 diabetes in people with impaired fasting glucose (ADA vs. WHO Criteria) and impaired glucose tolerance: Results from an older population (KORA S4/F4/FF4 Study). Diabetes Care 42, E18-E20:DC181473 (2019)
22.
Krischer, J.P.* et al.: Predicting islet cell autoimmunity and type 1 diabetes: An 8-year TEDDY study progress report. Diabetes Care 42, 1051-1060 (2019)
23.
Schlesinger, S.* et al.: General and abdominal obesity and incident distal sensorimotor polyneuropathy: Insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diabetes Care 42, 240-247 (2019)
24.
Winkler, C. et al.: Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes. Diabetes Care 42, 1684-1691 (2019)
25.
Andersen, S.T.* et al.: Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: Addition-Denmark. Diabetes Care 41, 1068-1075 (2018)
26.
Auzanneau, M.* et al.: Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: A cross-sectional multicenter DPV analysis. Diabetes Care 41, 2517-2525 (2018)
27.
Frank-Podlech, S. et al.: Leptin replacement reestablishes brain insulin action in the hypothalamus in congenital leptin deficiency. Diabetes Care 41, 907-910 (2018)
28.
Kähm, K. et al.: Health care costs associated with incident complications in patients with type 2 diabetes in Germany. Diabetes Care 41, 971-978 (2018)
29.
Uusitalo, U.* et al.: Early infant diet and islet autoimmunity in the TEDDY Study. Diabetes Care 41, 522-530 (2018)
30.
Herder, C.* et al.: Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Diabetes Care 40, 569-576 (2017)
31.
TEDDY Study Group (Hummel, S. ; Beyerlein, A. ; Ziegler, A.-G.) et al.: First infant formula type and risk of islet autoimmunity in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Care 40, 398-404 (2017)
32.
Johnson, S.B.* ; Lynch, K.F.* ; TEDDY Study Group (Roth, R.) & Schatz, D.*: My child is islet autoantibody positive: Impact on parental anxiety. Diabetes Care 40, 1167-1172 (2017)
33.
Kollerits, B.* et al.: Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: A pooled analysis in more than 20,000 individuals. Diabetes Care 40, 1386-1393 (2017)
34.
Krischer, J.P.* et al.: Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: The TEDDY Study. Diabetes Care 40, 1194-1202 (2017)
35.
Frank, S.* et al.: Neuronal food reward activity in patients with type 2 diabetes with improved glycemic control after bariatric surgery. Diabetes Care 39, 1311-1317 (2016)
36.
Jordan, J.* ; El-Armouche, A.* ; Hanefeld, M.* ; Bornstein, S.R. & Birkenfeld, A.L.: CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114. Diabetes Care 39, E224-E225 (2016)
37.
Vehik, K.* et al.: Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39, 1535-1542 (2016)
38.
Bonifacio, E.: Predicting type 1 diabetes using biomarkers. Diabetes Care 38, 989-996 (2015)
39.
Brandmaier, S. et al.: Response to Comment on Xu et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 2015;38:1858-1867. Diabetes Care 38, e216-e217 (2015)
40.
Herder, C.* et al.: Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: Results from the KORA F4 study. Diabetes Care 38, 91-96 (2015)